drugset / Trial / NCT02713191
Dexmedetomidine vs. Midazolam Sedation for Endobronchial Ultrasound
Phase 2/3
Completed
197 enrolled
Post Graduate Institute of Medical Education and Research, Chandigarh
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The randomized controlled trial will compare efficacy and safety of dexmedetomidine to midazolam for sedation during endobronchial ultrasound
Timeline
- Start
- 2016-03
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.6 ug/kg | Intravenous |
| Subject | Midazolam | Small molecule | 0.5 mg | Intravenous |
| Subject | Midazolam | Small molecule | 2 mg | Intravenous |
| Background | Fentanyl | Other / unclassified | 1 ug/kg | Intravenous |
Indications
No indication recorded.